Literature DB >> 8943443

Frequency of Doppler measurable pulmonary artery pressures.

D D Borgeson1, J B Seward, F A Miller, J K Oh, A J Tajik.   

Abstract

The current literature suggests that right-sided heart pressures can be obtained noninvasively in approximately 60% of patients. We hypothesized that with a focused echocardiographic Doppler examination, measurable tricuspid or pulmonary valve regurgitation suitable for measuring pressures could be obtained in a higher percentage of patients. The study group consisted of 200 consecutive patients undergoing echocardiographic and Doppler hemodynamic evaluation. All patients were first examined by an ultrasonographer instructed to attempt to record tricuspid and pulmonary regurgitant velocities. After this examination, a designated cardiologist performed a focused examination with the intent of improving the signal quality and increasing the number of measurable signals for evaluation. Tricuspid regurgitation of measurable quality was recorded in 147 (73.5%) of 200 patients by the ultrasonographer; this result was improved to 172 patients (86%) by the designated cardiologist. Pulmonary regurgitation was obtainable in 147 (95%) of 154 patients and was of measurable quality in 137 (89%). When results of tricuspid and pulmonary regurgitation were combined, a quantifiable signal was obtained in 194 (97%) of 200 consecutive unselected patients. This study demonstrates that a well-trained ultrasonographer or echocardiologist can obtain right-sided pressures in at least 95% of all unselected cardiovascular patients.

Entities:  

Mesh:

Year:  1996        PMID: 8943443     DOI: 10.1016/s0894-7317(96)90475-7

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  22 in total

1.  Effect of simulated diving trips on pulmonary artery pressure in healthy men.

Authors:  Jochen Hansel; Christof Burgstahler; Sabine Medler; Detlef Axmann; Andreas M Niess; Kay Tetzlaff
Journal:  Clin Res Cardiol       Date:  2012-06-14       Impact factor: 5.460

2.  Pulmonary regurgitation end-diastolic gradient is a Doppler marker of cardiac status: data from the Heart and Soul Study.

Authors:  Bryan Ristow; Syed Ahmed; Lianyi Wang; Haiying Liu; Brad G Angeja; Mary A Whooley; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2005-09       Impact factor: 5.251

Review 3.  Biomarkers in pulmonary arterial hypertension.

Authors:  Julie L Rosenthal; Miriam S Jacob
Journal:  Curr Heart Fail Rep       Date:  2014-12

4.  Accuracy of noninvasively determined pulmonary artery systolic pressure.

Authors:  Jeffrey M Testani; Martin G St John Sutton; Susan E Wiegers; Amit V Khera; Richard P Shannon; James N Kirkpatrick
Journal:  Am J Cardiol       Date:  2010-03-05       Impact factor: 2.778

5.  Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.

Authors:  Alison Morris; Matthew R Gingo; M Patricia George; Lorrie Lucht; Cathy Kessinger; Vikas Singh; Maria Hillenbrand; Michelle Busch; Deborah McMahon; Karen A Norris; Hunter C Champion; Mark T Gladwin; Yingze Zhang; Chad Steele; Frank C Sciurba
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

6.  A new method to estimate pulmonary vascular resistance using diastolic pulmonary artery-right ventricular pressure gradients derived from continuous-wave Doppler velocity measurements of pulmonary regurgitation.

Authors:  Sanae Kaga; Taisei Mikami; Michito Murayama; Kazunori Okada; Nobuo Masauzi; Masahiro Nakabachi; Hisao Nishino; Shinobu Yokoyama; Mutsumi Nishida; Taichi Hayashi; Daisuke Murai; Hiroyuki Iwano; Mamoru Sakakibara; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-30       Impact factor: 2.357

7.  Assessment of pulmonary arterial hypertension and vascular resistance by measurements of the pulmonary arterial flow velocity curve in the absence of a measurable tricuspid regurgitant velocity in childhood congenital heart disease.

Authors:  Ayhan Cevik; Serdar Kula; Rana Olgunturk; F Sedef Tunaoglu; A Deniz Oguz; Berna Saylan; Erman Cilsal; Cihat Sanli
Journal:  Pediatr Cardiol       Date:  2012-10-05       Impact factor: 1.655

8.  Serum (1→3)-β-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary function.

Authors:  Alison Morris; Maria Hillenbrand; Malcolm Finkelman; M Patricia George; Vikas Singh; Cathy Kessinger; Lorrie Lucht; Michelle Busch; Deborah McMahon; Renee Weinman; Chad Steele; Karen A Norris; Matthew R Gingo
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

9.  Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.

Authors:  Rushi V Parikh; Rebecca Scherzer; Elaine M Nitta; Anna Leone; Sophia Hur; Vanita Mistry; John S Macgregor; Jeffrey N Martin; Steven G Deeks; Peter Ganz; Priscilla Y Hsue
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

10.  Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension.

Authors:  Priscilla Y Hsue; Steven G Deeks; Husam H Farah; Swapna Palav; Samira Y Ahmed; Amanda Schnell; Allison B Ellman; Laurence Huang; Sheila C Dollard; Jeffrey N Martin
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.